Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening
As of December 2009, cystic fibrosis (CF) newborn screening (NBS) is performed in all 50 US states and the District of Columbia. Widespread implementation of CF newborn screening (CFNBS) in the US and internationally has brought about new and varied challenges. Immunoreactive trypsinogen (IRT) remai...
Main Authors: | Joan Kathleen DeCelie-Germana, Lynn Bonitz, Elinor Langfelder-Schwind, Catherine Kier, Barry Lawrence Diener, Maria Berdella |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/13/8/1646 |
Similar Items
-
Missed Cystic Fibrosis Newborn Screening Cases due to Immunoreactive Trypsinogen Levels below Program Cutoffs: A National Survey of Risk Factors
by: Martin Kharrazi, et al.
Published: (2022-10-01) -
Reproductive Counseling and Care in Cystic Fibrosis: A Multidisciplinary Approach for a New Therapeutic Era
by: Julie McGlynn, et al.
Published: (2023-07-01) -
Newborn Screening Program for Cystic Fibrosis in Cuba: Three Years’ Experience
by: Elisa M. Castells, et al.
Published: (2023-06-01) -
Cystic Fibrosis Newborn Screening in Portugal: PAP Value in Populations with Stringent Rules for Genetic Studies
by: Ana Marcão, et al.
Published: (2018-06-01) -
Newborn Screening for Cystic Fibrosis in Russia: A Catalyst for Improved Care
by: Victoria Sherman, et al.
Published: (2020-04-01)